Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Donna Shaler
ResearcherPublications, citations & collaboration network
Donna Shaler is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 4 works, 233 citations, an h-index of 4 and an i10-index of 3.
4
Works
233
Citations
4
h-index
3
i10-index
IDs:OpenAlex
How has Donna Shaler's publication output changed over time?
ScholarIQpublication output · 2018–2022
Output grew0% over the shown period — from 1 works in 2018 to 1 in 2022.
1
1
1
1
2018202020212022
What are the most-cited papers on Donna Shaler?
ScholarIQmost cited works
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Karen Elkind‐Hirsch, Neil Chappell, Donna Shaler, John Storment, Drake E. Bellanger
Fertility and Sterility. 2022165 CitationsOPEN ACCESS
Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study
Karen Elkind‐Hirsch, Donna Shaler, Renee Harris
Journal of Diabetes and its Complications. 202043 Citations
Short-Term Sitagliptin-Metformin Therapy Is More Effective Than Metformin Or Placebo In Prior Gestational Diabetic Women With Impaired Glucose Regulation
Karen Elkind‐Hirsch, Martha S. Paterson, Donna Shaler, Hanh C. Gutowski
Endocrine Practice. 201821 Citations
A randomized, double-blind, placebo-controlled study of liraglutide 3 mg [LIRA 3mg] on weight, body composition, hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome (PCOS)
Karen Elkind‐Hirsch, Neil Chappell, Donna Shaler, John Storment, Drake E. Bellanger
Research Square. 20214 CitationsOPEN ACCESS
Related on ScholarIQ
Woman's Hospital
Institution
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Paper
Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study
Paper
Short-Term Sitagliptin-Metformin Therapy Is More Effective Than Metformin Or Placebo In Prior Gestational Diabetic Women With Impaired Glucose Regulation
Paper
A randomized, double-blind, placebo-controlled study of liraglutide 3 mg [LIRA 3mg] on weight, body composition, hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome (PCOS)
Paper
Diabetes Treatment and Management
Topic